We are live on ! Find out more
KURA icon

Kura Oncology
KURA

30 hedge funds and large institutions have $58.2M invested in Kura Oncology in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

46.22% more ownership

Funds ownership: 0% → 46.22% (+46%)

17% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 6

7% more funds holding

Funds holding: 28 → 30 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less capital invested

Capital invested by funds: $60.9M → $58.2M (-$2.69M)

Holders
30
Holders Change
+2
Holders Change %
+7.14%
% of All Funds
0.75%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
7
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$801K
2
JMPWA
JP Morgan Private Wealth Advisors
California
+$158K
3
Squarepoint
Squarepoint
New York
+$67.1K
4
OC
Oppenheimer & Co
New York
+$58.4K
5
Deutsche Bank
Deutsche Bank
Germany
+$45.3K

Top Sellers

Rank Fund Capital Flow
1
BC
Birchview Capital
Vermont
-$369K
2
PHS
PFM Health Sciences
California
-$157K
3
CCP
Clough Capital Partners
Massachusetts
-$57.7K
4
UBS Group
UBS Group
Switzerland
-$9.99K
5
MA
MUFG Americas
New York
-$3.06K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$16.6M – – –
EC
2
EcoR1 Capital
California
$15.4M – – –
PHS
3
PFM Health Sciences
California
$11.7M -$157K -29,213 -1%
CCP
4
Clough Capital Partners
Massachusetts
$3.9M -$57.7K -10,770 -2%
BC
5
Boxer Capital
California
$3.15M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$2.21M +$12.3K +2,300 +0.6%
MA
7
Minerva Advisors
Pennsylvania
$1.87M – – –
Morgan Stanley
8
Morgan Stanley
New York
$922K +$801K +149,372 +2,168%
ACM
9
Alethea Capital Management
Washington
$379K – – –
BCM
10
Bridgeway Capital Management
Texas
$372K – – –
Geode Capital Management
11
Geode Capital Management
Massachusetts
$290K +$1.52K +284 +0.6%
BFA
12
BlackRock Fund Advisors
California
$212K +$4.73K +882 +3%
Renaissance Technologies
13
Renaissance Technologies
New York
$181K +$33.2K +6,200 +25%
PPCM
14
Pillar Pacific Capital Management
California
$180K – – –
JMPWA
15
JP Morgan Private Wealth Advisors
California
$174K +$158K +29,500 New
PIM
16
Partner Investment Management
California
$139K -$193 -36 -0.2%
California Public Employees Retirement System
17
California Public Employees Retirement System
California
$139K – – –
Squarepoint
18
Squarepoint
New York
$74K +$67.1K +12,518 New
Northern Trust
19
Northern Trust
Illinois
$73K +$8.02K +1,495 +14%
OC
20
Oppenheimer & Co
New York
$64K +$58.4K +10,900 New
PAM
21
Panagora Asset Management
Massachusetts
$58K – – –
Deutsche Bank
22
Deutsche Bank
Germany
$50K +$45.3K +8,451 +8,451%
Acadian Asset Management
23
Acadian Asset Management
Massachusetts
$46K +$42.1K +7,860 New
Citigroup
24
Citigroup
New York
$33K – – –
BIM
25
BlackRock Investment Management
Delaware
$15K – – –
1
2

KURA Hedge Fund Activity: Q4 2016 in Review

30 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q4 2016, worth a combined $58.2M — down 4.4% from $60.9M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new KURA positions and 2 closed out — a net gain of 2 holders — while 7 added to existing stakes and 6 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $801K. The largest seller was Birchview Capital, exiting entirely with an estimated $369K sold.

  • 30 institutional investors held Kura Oncology (KURA) as of Q4 2016, up from 28 in Q3 2016.
  • Funds reported $58.2M of Kura Oncology stock for Q4 2016, down 4.4% quarter-over-quarter.
  • 4 funds opened new Kura Oncology positions in Q4 2016 and 2 closed out, a net change of +2 holders.
  • The largest Kura Oncology buyer in Q4 2016 was Morgan Stanley, an estimated $801K added.
  • The largest Kura Oncology seller in Q4 2016 was Birchview Capital, an estimated $369K sold.

Based on aggregated 13F filings for Q4 2016.